Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation-American Red Cross webinar

🔬 Mixed-Field ABO Front Typing as an Early Sign of Disease Recurrence in ABO-Matched Stem Cell Transplantation

A recent American Red Cross webinar highlights the significance of mixed-field ABO front typing in detecting early disease recurrence post-transplant.

🩸 Key Insights:
🔹 Mixed-field reactions could indicate relapse or donor-host interactions
🔹 ABO typing may serve as a valuable monitoring tool in transplant recipients
🔹 Clinical implications for transfusion management & post-transplant care

This engaging session will feature the article’s authors, esteemed experts Nalan Yurtsever, MD and Christopher Tormey, MD from Yale School of Medicine. They will lead a live discussion of their research and findings. The session will be expertly moderated by Janis R. Hamilton, MS, MLS(ASCP)SBB

How should transfusion medicine specialists interpret mixed-field typing results in transplant patients? Let’s discuss the clinical significance!

Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation